Atomistry » Chlorine » PDB 5mls-5mtp » 5mo4
Atomistry »
  Chlorine »
    PDB 5mls-5mtp »
      5mo4 »

Chlorine in PDB 5mo4: ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib

Enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib

All present enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib:
2.7.10.2;

Protein crystallography data

The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4 was solved by S.W.Cowan-Jacob, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 59.14 / 2.17
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 118.280, 124.130, 74.660, 90.00, 90.00, 90.00
R / Rfree (%) 18.2 / 21.7

Other elements in 5mo4:

The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib also contains other interesting chemical elements:

Fluorine (F) 5 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib (pdb code 5mo4). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4:

Chlorine binding site 1 out of 1 in 5mo4

Go back to Chlorine Binding Sites List in 5mo4
Chlorine binding site 1 out of 1 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl602

b:26.2
occ:1.00
CL A:AY7602 0.0 26.2 1.0
C28 A:AY7602 1.8 29.4 1.0
F30 A:AY7602 2.5 31.4 1.0
F29 A:AY7602 2.7 28.6 1.0
O22 A:AY7602 2.7 28.8 1.0
C19 A:AY7602 3.2 28.7 1.0
O A:LEU448 3.3 24.8 1.0
C20 A:AY7602 3.6 25.5 1.0
CG2 A:ILE451 3.8 24.6 1.0
N A:ALA452 3.9 24.0 1.0
CG1 A:VAL487 4.0 25.4 1.0
CB A:ILE451 4.0 24.8 1.0
CD1 A:LEU448 4.0 31.8 1.0
CG A:LEU448 4.1 31.3 1.0
C A:LEU448 4.1 26.3 1.0
CB A:ALA452 4.1 23.8 1.0
C18 A:AY7602 4.1 29.5 1.0
CA A:LEU448 4.2 23.9 1.0
CA A:ALA452 4.3 23.7 1.0
CB A:ALA363 4.5 23.0 1.0
C A:ILE451 4.5 28.0 1.0
CB A:LEU448 4.6 25.0 1.0
C21 A:AY7602 4.6 26.9 1.0
CA A:ILE451 4.8 22.8 1.0
CE A:MET491 4.9 26.9 1.0

Reference:

A.A.Wylie, J.Schoepfer, W.Jahnke, S.W.Cowan-Jacob, A.Loo, P.Furet, A.L.Marzinzik, X.Pelle, J.Donovan, W.Zhu, S.Buonamici, A.Q.Hassan, F.Lombardo, V.Iyer, M.Palmer, G.Berellini, S.Dodd, S.Thohan, H.Bitter, S.Branford, D.M.Ross, T.P.Hughes, L.Petruzzelli, K.G.Vanasse, M.Warmuth, F.Hofmann, N.J.Keen, W.R.Sellers. The Allosteric Inhibitor ABL001 Enables Dual Targeting of Bcr-ABL1. Nature V. 543 733 2017.
ISSN: ESSN 1476-4687
PubMed: 28329763
DOI: 10.1038/NATURE21702
Page generated: Fri Jul 26 12:48:41 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy